Ovary and pregnancy

The ovary does not suddenly cease to be relevant after conception, but undergoes a profound functional reconfiguration in which its dominant role shifts from the cyclical production of an ovulatory follicle to the endocrine maintenance of the early gestational environment through the corpus luteum. During the first weeks, continuation of the pregnancy depends on the ability of the luteinized ovary to produce progesterone, estradiol, relaxin and other mediators that are essential for secretory transformation of the endometrium, stabilization of the decidua, modulation of maternal vascular function and support of implantation until the placenta acquires sufficient steroidogenic competence. Pregnancy therefore does not abolish ovarian physiology, but converts it into a highly specialized endocrine support function.

From a clinical perspective, the relationship between the ovary and pregnancy encompasses at least three major areas. The first is physiological and concerns ovulation, fertilization, corpus luteum formation and transfer of hormone production to the placenta. The second concerns the effects that preexisting ovarian disorders, such as polycystic ovary syndrome, primary ovarian insufficiency, endometriosis or diminished ovarian reserve, may have on conception, the obstetric course and reproductive prognosis. The third concerns conditions that arise or are recognized during gestation, such as ovarian cysts, adnexal masses, ovarian torsion and rare forms of hyperstimulation or pathological luteinization. For this reason, the management of ovarian function during pregnancy requires an integrated approach involving reproductive physiology, endocrinology, obstetric and gynecological ultrasound and conservative surgery when necessary.

Pregnancy begins biologically as an ovary dependent event. After ovulation, the dominant follicle collapses, reorganizes and undergoes luteinization, forming the corpus luteum. In a cycle without conception, this transient endocrine gland has a limited lifespan and rapidly regresses, with a decline in progesterone and estradiol. When fertilization occurs and the embryo implants, the trophoblast produces hCG, which prolongs the lifespan of the corpus luteum and maintains its steroidogenesis. Early pregnancy is therefore a condition in which the ovary remains essential, because survival of the conceptus depends on persistence of luteal function.

Luteal progesterone is central to this transition. It induces secretory transformation of the endometrium, promotes decidualization of the stroma, reduces myometrial contractile activity, modulates maternal and embryonic immune interactions and prepares an environment suitable for trophoblastic invasion. Estradiol produced by the corpus luteum acts synergistically by supporting uterine growth, endometrial receptivity and regulation of blood flow. These hormones are accompanied by mediators such as relaxin, which appear to contribute to maternal vascular and renal adaptation during the early stages of pregnancy. The ovary during early gestation is therefore not merely a remnant of the menstrual cycle, but a temporary gland with systemic functions.

The most critical period is the first trimester, when the placenta is progressively acquiring endocrine capacity but has not yet completely replaced the corpus luteum. During this period, the luteoplacental transition takes place, meaning the gradual transfer of steroid production from the ovary to the placenta. This transition does not occur on a single day, but develops progressively through biologically overlapping phases. Until the placenta becomes fully autonomous, impairment of luteal function may result in endocrine instability during early pregnancy. This explains why the corpus luteum retains tangible clinical relevance during the first weeks, particularly in pregnancies achieved through assisted reproductive protocols without a physiological corpus luteum.

As gestation progresses, the ovary loses its dominant role in steroidogenesis because the placenta progressively assumes the primary role in progesterone and estrogen production. From this point onward, ovarian physiology does not stop completely, but enters a phase of relative functional quiescence. The gestational endocrine environment, characterized by high progesterone and estrogen levels and gonadotropin suppression, prevents recruitment leading to a new ovulation. The ovary during pregnancy therefore does not continue the follicular cyclicity typical of the reproductive years, but remains regulated by a profoundly different systemic environment directed toward maintenance of pregnancy rather than repetition of the menstrual cycle.

This reorganization also has morphological consequences. During the early stages, the corpus luteum can be identified by ultrasound, often as a cystic structure with thickened, vascularized walls. Its persistence during the first weeks should not be interpreted as pathological, but as an expression of the normal endocrinology of pregnancy. At the same time, follicular activity is functionally suppressed. Abnormal ovarian responses, such as theca lutein cysts or pregnancy related hyperstimulation syndromes, occur only in specific settings, including multiple pregnancies, exposure to high hCG levels or particular individual predispositions.

In summary, the ovary undergoes two main functional phases during pregnancy: an essential luteal phase during the first weeks and a subsequent phase of reduced endocrine activity after placental function has become established. Understanding this sequence is essential for the correct interpretation of early pregnancy physiology, early bleeding, luteal support in medically assisted pregnancies and the appearance of functional adnexal masses.

The relationship between the ovary and pregnancy is strongly influenced by the quality of ovarian function before conception. The probability of spontaneous conception depends on regular ovulation, oocyte competence, follicular reserve and the endocrine and metabolic environment accompanying follicular maturation. Ovarian conditions that alter one or more of these processes therefore affect not only the time required to achieve pregnancy, but may also modify the risk of early pregnancy loss, obstetric complications and the need for assisted reproductive technologies. In other words, the epidemiology of pregnancy cannot be separated from the epidemiology of ovarian function.

The most common clinically relevant ovarian condition affecting pregnancy is PCOS. In these patients, the initial problem is often anovulation or chronic ovulatory dysfunction, but once conception has occurred the risk does not automatically return to that of the general population. The association with obesity, insulin resistance, hyperandrogenism, low grade inflammation and cardiometabolic dysfunction contributes to a more vulnerable obstetric profile, with a greater probability of gestational diabetes, hypertensive disorders of pregnancy and other complications. The relative contribution of individual factors varies among women, but the clinical principle remains that pregnancy in women with PCOS requires more accurate risk stratification than the mere confirmation that conception has occurred.

At the other end of the spectrum are patients with primary ovarian insufficiency or a severe reduction in ovarian reserve. In these cases, spontaneous pregnancy is less likely because fewer competent follicles are available or because ovarian function is intermittent. However, the situation is not absolute, since residual follicular activity may persist in a proportion of patients with primary ovarian insufficiency and sporadic ovulations may occur. This has two clinical implications. Fertility should not automatically be considered absent, but reproductive planning requires early counselling because reproductive potential may decline unpredictably and rapidly.

A highly important epidemiological determinant is ovarian age, meaning the relationship between chronological age and the progressive quantitative and qualitative reduction in the oocyte pool. As age advances, the frequency of oocyte aneuploidy increases, the probability of pregnancy per cycle decreases and the risk of early pregnancy loss rises. This phenomenon does not concern only advanced reproductive age, but becomes clinically relevant during the reproductive transition when ovarian reserve begins to decline despite apparently regular menstrual cycles. The ovary therefore affects not only the possibility of conception, but also the biological stability of the resulting embryo.

The ovarian environment associated with endometriosis, previous ovarian surgery, chemotherapy, radiotherapy or genetic mutations may also affect reproductive outcomes. In some women, the main problem is quantitative, as in the loss of functional ovarian tissue. In others, it is qualitative, involving alterations of the follicular microenvironment, the oocyte or the endocrine response. Furthermore, some reproductive techniques required to overcome ovarian impairment may themselves modify the endocrine context of early pregnancy, particularly when conception occurs in the absence of a physiological corpus luteum.

In epidemiological terms, pregnancy depends on an ovarian history that begins before conception. Obstetric risk assessment should therefore integrate ovulatory regularity, ovarian age, ovarian reserve, metabolic status, previous gonadotoxic exposure, diagnoses of PCOS or ovarian insufficiency and the method through which pregnancy was achieved.

The most important pathophysiological aspect of the ovary during pregnancy concerns the corpus luteum. After ovulation, the dominant follicle transforms into a highly vascularized structure composed of luteal cells derived from the granulosa and theca. This transformation is induced by the LH surge and enables substantially greater progesterone production than during the follicular phase. When conception does not occur, the absence of a rescue signal leads to luteolysis. When pregnancy is established, embryonic and placental hCG binds to luteal receptors and maintains active steroidogenesis. This mechanism is the first biological bridge between the embryo and the maternal ovary.

The corpus luteum of pregnancy does not merely provide a quantitative endocrine function, but represents a true interface between ovulation and successful implantation. Luteal progesterone induces transcriptional changes in the endometrium, promotes decidual differentiation and supports the local immune environment that allows the trophoblast to implant without rejection. The quality of luteal function depends on the follicle from which the corpus luteum developed, luteal vascularization, the response to LH and hCG and the woman's metabolic integrity. The luteal phase is therefore not a marginal segment of the menstrual cycle, but the decisive phase connecting ovulation with early pregnancy.

The luteoplacental transition consists of the gradual transfer of endocrine dominance from the ovary to the placenta. During the first weeks, progesterone is derived largely from the corpus luteum. The placenta subsequently acquires the ability to produce sufficient quantities to maintain the pregnancy autonomously. This process is made possible by trophoblastic maturation and activation of placental steroidogenesis. Clinically, this transition explains why luteal support is particularly relevant during the first trimester and why pregnancies with an iatrogenic absence of a corpus luteum may have a distinctive hemodynamic and hormonal profile.

A natural pregnancy with a corpus luteum and a pregnancy achieved through a programmed cycle without ovulation are not endocrinologically identical. When a corpus luteum does not form, the early maternal environment lacks not only physiological endogenous progesterone, but also other luteal products such as relaxin, with potential effects on early cardiovascular adaptation. This observation is increasingly relevant in reproductive medicine because it suggests that the ovary is not merely a source of replaceable steroids, but also produces paracrine and endocrine signals that may influence the quality of gestational adaptation.

On ultrasound, the corpus luteum may appear as a functional cyst, sometimes hemorrhagic, with characteristic peripheral vascularization. In most cases, this is a physiological or paraphysiological finding that requires no intervention. Correct identification is important to avoid diagnostic confusion with ovarian ectopic pregnancy, pathological cysts or more complex adnexal masses. Mild unilateral pain or the incidental finding of a corpus luteum cyst during the first weeks of pregnancy also commonly falls within the physiological spectrum.

In summary, the corpus luteum lies at the heart of the relationship between the ovary and early pregnancy. Without adequate luteal function, implantation cannot become established, the decidua cannot be maintained and the placenta does not have sufficient time to acquire endocrine autonomy. The entire physiology of early pregnancy arises from this continuity between ovulation, luteinization and embryonic signaling.

Pregnancy develops on a preexisting ovarian background that may be normal or pathological. In PCOS, the main difficulty before conception is often irregular ovulation, but the effects of the syndrome extend beyond the ability to become pregnant. Hyperinsulinemia, androgen excess, visceral adiposity, endothelial dysfunction and an altered inflammatory profile may influence implantation, placentation and maternal adaptation. Pregnancy in a woman with PCOS therefore requires specific attention not only to blood glucose, but also to blood pressure, weight gain, thrombotic and metabolic risk and psychological well being.

Endometriosis represents another relevant area. Although many women with endometriosis conceive spontaneously, the disease may interfere with fertility through anatomical abnormalities, pelvic inflammation, reduced oocyte quality and possible alterations in endometrial receptivity. Once pregnancy has been established, most lesions tend to enter a phase of reduced clinical activity because of the progestogenic environment. However, problems may remain, including persistent endometriomas, abdominal and pelvic pain requiring differential diagnosis and difficulties in the ultrasound interpretation of preexisting adnexal masses.

In patients with primary ovarian insufficiency or intermittent ovarian function, pregnancy is often preceded by complex diagnostic and therapeutic pathways. When pregnancy occurs spontaneously or through assisted reproduction, a distinction must be made between residual endogenous ovarian function and pregnancy achieved using donated oocytes or hormone replacement protocols. This has not only reproductive but also endocrine implications, because luteal support, the initial hormonal profile and the presence or absence of a corpus luteum may differ considerably. Furthermore, systemic conditions associated with certain forms of ovarian insufficiency, such as autoimmunity or genetic comorbidities, may influence obstetric care.

Women with a history of ovarian surgery, conservatively treated torsion, repeated cystectomies or gonadotoxic treatment represent a group in whom conception may already have been selectively limited by reduced ovarian function. Pregnancy is not necessarily more fragile by definition, but impaired ovarian reserve remains relevant to future reproductive planning, the possibility of subsequent pregnancies and postpartum counselling. In these patients, the clinical significance of the ovary during pregnancy therefore extends beyond the individual gestation and concerns the overall reproductive trajectory.

An important point is that not all preexisting ovarian dysfunctions retain the same relevance throughout pregnancy. Some primarily affect conception, as occurs with chronic ovulatory dysfunction. Others influence gestational adaptation, as occurs with the metabolic burden of PCOS. Others complicate ultrasound monitoring or surgical management, as occurs with endometriomas or persistent adnexal masses. Pregnancy therefore does not erase the previous ovarian history, but transforms it into a different clinical risk profile.

In summary, adaptation to pregnancy also depends on the ovarian physiology and pathology that precede it. A detailed ovarian and reproductive history is therefore an integral part of the initial obstetric assessment and guides screening, counselling and follow up throughout gestation.

Adnexal masses during pregnancy represent a distinct clinical issue because the frequent benign nature of these findings must be balanced against the need to promptly identify the few cases requiring intervention. Many ovarian formations identified during the first trimester are functional, particularly corpus luteum cysts or residual simple follicular cysts, and a substantial proportion regress spontaneously during gestation. This principle is crucial because ultrasound identification of an ovarian mass during pregnancy does not automatically constitute an indication for surgery. The correct approach is based on morphological characterization, symptoms, dimensions, evolution over time and oncological suspicion.

A cystic corpus luteum is the formation most characteristically associated with early pregnancy. It may appear complex, with hemorrhagic content, thickened walls and intense peripheral vascularization. In the absence of signs of rupture, torsion or suspected malignancy, management is generally conservative. Its presence should in fact serve as a reminder that this structure is biologically useful during the first weeks. The opposite error, treating a physiological luteal formation as pathological, may expose the patient to unnecessary and potentially harmful interventions during a phase in which the ovary still performs an important endocrine role.

Among the acute complications of ovarian masses during pregnancy, the most concerning is adnexal torsion. Risk increases in the presence of enlarged ovaries or mobile cysts, and the condition presents with acute abdominal pain, nausea, vomiting and ultrasound findings that may be suggestive but are not always conclusive. Diagnosis is therefore primarily clinical and sonographic, and prompt recognition is essential because delay may compromise ovarian viability. When torsion is probable, conservative surgery with detorsion and preservation of the ovary represents the modern treatment principle, except in specific circumstances.

Another characteristic condition is represented by theca lutein cysts, which may develop in the presence of elevated hCG levels, as in multiple pregnancies, gestational trophoblastic disease or some complicated pregnancies. The ovaries are bilaterally enlarged and contain multiple cysts as a result of excessive luteal stimulation. Treatment is conservative in most cases, and the condition regresses as the hCG stimulus decreases. However, increased ovarian size may predispose to pain, torsion and difficulties in differential diagnosis.

The most complex issue is the distinction between a benign mass and an ovarian neoplasm. During pregnancy, assessment is based primarily on expert ultrasound evaluation, taking into account thick septa, papillary projections, solid components, ascites, bilateral involvement, progressive growth and persistence. Serum markers have limited value because some may be physiologically altered by pregnancy. In suspicious cases, the timing and extent of surgery must balance maternal risk, fetal risk and the probability of malignancy. The latter part of the second trimester is often the most favorable period for nonurgent surgery, but the decision must remain individualized.

In summary, most ovarian masses during pregnancy are benign and suitable for observation, but a minority require close surveillance or treatment because of acute symptoms, persistence, high risk ultrasound features or suspected neoplasia. The quality of ultrasound assessment and the experience of the clinical team are essential to avoid both excessive intervention and dangerous delays.

Clinical assessment of the ovary during pregnancy should follow a pathway beginning with the reproductive history and progressing, when necessary, to integration of ultrasound, laboratory testing and serial observation. The initial assessment includes previous menstrual and ovulatory history, diagnoses of PCOS, endometriosis or ovarian insufficiency, adnexal surgery, assisted reproductive procedures, previous torsion, chronic pelvic pain and the method through which pregnancy was achieved. These elements already guide assessment of the need for luteal support, metabolic risk, known masses or the possibility of an early pregnancy without a physiological corpus luteum.

During the first trimester, transvaginal ultrasound is the principal diagnostic tool. It confirms the location of the pregnancy, identifies the corpus luteum, describes any ovarian cysts, recognizes complex masses and assesses indirect signs of complications such as hemoperitoneum or torsion. Correct localization of the corpus luteum is particularly useful in the differential diagnosis of ectopic pregnancy or unilateral adnexal pain. Morphological assessment must be accurate but contextualized, because pregnancy modifies the significance of some findings and increases the frequency of functional and paraphysiological structures.

Laboratory tests have a selective role. Serial measurement of hCG is primarily useful in early pregnancies of unknown location or uncertain viability, while progesterone and other hormones have limited value when interpreted outside the clinical context. In patients with suspected PCOS or preexisting metabolic dysfunction, assessment should include early evaluation of glycemic and blood pressure risk. The purpose is not to diagnose the ovary during pregnancy, but to recognize that pregestational ovarian pathology may translate into a biologically more vulnerable pregnancy. In patients with previous ovarian insufficiency or pregnancies achieved through oocyte donation, the clinical history is often more informative than an isolated gestational laboratory result.

When an adnexal mass persists or has uncertain characteristics, serial ultrasound follow up becomes the principal method for distinguishing physiological regression, benign stability and suspicious progression. Absence of growth, morphological simplification and disappearance over time support observational management. Conversely, persistence beyond the first trimester, increasing size, development of solid components or recurrent symptoms shift the balance toward further investigation or surgical assessment. In selected cases, magnetic resonance imaging without contrast may be useful for improved anatomical characterization.

Follow up must be tailored to the nature of the problem. In women with PCOS, obstetric monitoring should include early attention to weight, blood pressure and glucose metabolism. In patients with adnexal masses managed conservatively, an ultrasound schedule proportionate to the level of risk is essential. In pregnancies achieved after ovarian insufficiency or complex reproductive treatment, counselling should clarify the role of luteal support, the meaning of current treatment and the timing of possible discontinuation. Monitoring is therefore not uniform, but is constructed around the individual ovarian profile.

In summary, diagnosis of ovarian conditions during pregnancy does not depend on a single test, but on a dynamic interpretation of ovarian history, ultrasound findings and clinical risk. This approach is the only one that permits correct management of the broad area of overlap between gestational physiology and genuine adnexal disease.

Treatment of ovarian conditions during pregnancy is based on the fundamental principle of simultaneously preserving maternal safety, fetal viability and, whenever possible, ovarian integrity. During physiological early pregnancy, treatment of the ovary often consists of avoiding intervention and recognizing the normal nature of the corpus luteum and small functional cysts. This conservative approach is an integral part of good clinical practice because it reduces unnecessary procedures during a phase in which the ovary still provides essential endocrine support.

In pregnancies at risk of inadequate luteal support, particularly after certain assisted reproductive procedures or in protocols without spontaneous ovulation, exogenous progesterone is the cornerstone of treatment. Its rationale is physiological rather than empirical, since it replaces or supplements corpus luteum production until the placenta acquires adequate endocrine autonomy. The duration and method of support depend on the reproductive protocol, the presence or absence of a corpus luteum and the practices of the treating center, but the general principle remains support of the endocrine window during the first trimester.

In women with PCOS, treatment during pregnancy is no longer directed toward inducing ovulation, but toward managing the associated obstetric risk. This requires attention to weight gain, blood pressure monitoring, metabolic screening and control of comorbidities. Some patients enter pregnancy while receiving metformin or after ovulation induction treatments, but management during gestation must subsequently be recalibrated according to obstetric physiology rather than solely according to the original ovulatory disorder. In these women, the quality of care depends considerably on preconception assessment and continuity of follow up.

Asymptomatic adnexal masses with benign features are generally managed through observation. In contrast, acute pain caused by torsion, suspected rupture, hemoperitoneum, persistence of clinically significant masses or oncological suspicion are the principal indications for surgery. When surgery is necessary, the modern objective is to remain as conservative as possible, favoring detorsion, targeted cystectomy or limited treatment compatible with oncological and obstetric safety. Laparoscopy is often feasible in experienced hands, with timing and techniques adapted to gestational age and the clinical situation.

In the rare event of an ovarian neoplasm diagnosed during pregnancy, treatment should be planned in a referral center through collaboration between gynecological oncology and maternal and fetal medicine. The strategy depends on gestational age, the suspected histological type, disease extent and maternal condition. The principle is to avoid both unjustified delay in treating malignancy and interventions that are more aggressive than necessary for lesions with a low probability of malignancy. The quality of ultrasound assessment and preoperative staging also has a profound influence on decision making.

In summary, treatment of ovarian conditions during pregnancy requires proportionality. Intervention is indicated when the risk of inaction exceeds the risk of treatment, while observation is appropriate when physiological or benign features make intervention unnecessary. The guiding criterion is not the mere presence of an ovarian finding, but its actual biological and obstetric significance.

Complications involving the ovary during pregnancy may result from altered first trimester physiology, preexisting ovarian disease or the development of adnexal masses during gestation. During early pregnancy, the main area of vulnerability is dependence on the corpus luteum before full placental autonomy has been achieved. Inadequate luteal function, particularly in iatrogenic or high risk settings, may contribute to early pregnancy instability. In clinical practice, however, assessment of this risk must remain cautious and contextualized, avoiding simplistic diagnoses of luteal phase insufficiency that are not supported by the clinical findings.

In women with PCOS, complications develop along an obstetric and metabolic axis. The increased risk of gestational diabetes, hypertensive disorders, excessive weight gain and possible neonatal complications does not depend on a single mechanism, but on the convergence of insulin resistance, obesity, hyperandrogenism, endothelial dysfunction and fertility that has often been achieved after complex therapeutic pathways. Pregnancy in these patients should therefore be interpreted as a continuation of preexisting metabolic vulnerability rather than as a biological event separate from the ovarian syndrome.

In the setting of ovarian masses, the principal acute complications are torsion, rupture, bleeding and persistent pain. These are accompanied by a diagnostic complication, namely the risk of interpreting a functional finding as pathological or, conversely, underestimating a complex mass with genuine clinical significance. When surgery becomes necessary, potential complications include loss of ovarian tissue, anesthetic risk, uterine irritability and the need for more extensive procedures than anticipated if oncological suspicion increases during surgery.

Patients with primary ovarian insufficiency or a history of gonadotoxic injury face a different problem. Even when pregnancy progresses successfully, future reproductive prognosis remains an important concern. A successful gestation does not necessarily indicate stable recovery of ovarian function, and the postpartum period may again reveal diminished reserve or intermittent insufficiency. Postpartum counselling should therefore include contraception when necessary, planning of further pregnancies and reproductive endocrine reassessment when indicated.

Quality of life is an often underestimated aspect. Pain caused by ovarian masses, uncertainty regarding a persistent cyst, fear of pregnancy loss when luteal support is required, or pregnancy achieved after prolonged ovarian infertility all represent substantial emotional burdens. The patient experiences not only an anatomical or hormonal problem, but also a state of reproductive vulnerability requiring clear communication, consistent monitoring and reduction of unnecessary uncertainty. The quality of care depends considerably on the ability to explain when a finding is physiological, when it requires observation and when action is necessary.

In summary, the success of ovarian care during pregnancy is measured not only by continuation of the pregnancy, but by the ability to protect early implantation, maternal adaptation, ovarian integrity, surgical safety when intervention is required and future reproductive planning. This requires progressive, proportionate management centered on the genuine clinical significance of ovarian function throughout pregnancy.